157 related articles for article (PubMed ID: 21357300)
21. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
22. Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication.
Maiti M; Maiti M; Rozenski J; De Jonghe S; Herdewijn P
Org Biomol Chem; 2015 May; 13(18):5158-74. PubMed ID: 25849139
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.
Shi J; Zhou L; Zhang H; McBrayer TR; Detorio MA; Johns M; Bassit L; Powdrill MH; Whitaker T; Coats SJ; Götte M; Schinazi RF
Bioorg Med Chem Lett; 2011 Dec; 21(23):7094-8. PubMed ID: 22014549
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
[TBL] [Abstract][Full Text] [Related]
25. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256.
Yang H; Yang C; Wang Y; Rhodes G; Robinson M; Cheng G; Qi X; Mo H; Tian Y; Pakdaman R; Sheng XC; Kim CU; Delaney WE
Antivir Ther; 2017; 22(5):413-420. PubMed ID: 28106531
[TBL] [Abstract][Full Text] [Related]
26. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
27. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
[TBL] [Abstract][Full Text] [Related]
28. A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-
Karuna R; Yokokawa F; Wang K; Zhang J; Xu H; Wang G; Ding M; Chan WL; Abdul Ghafar N; Leonardi A; Seh CC; Seah PG; Liu W; Srinivasa RPS; Lim SP; Lakshminarayana SB; Growcott E; Babu S; Fenaux M; Zhong W; Gu F; Shi PY; Blasco F; Chen YL
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958712
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of imidazole N-H substituted amide prodrugs as inhibitors of hepatitis C virus replication.
Zong X; Cai J; Chen J; Wang P; Zhou G; Chen B; Li W; Ji M
Bioorg Med Chem Lett; 2015 Aug; 25(16):3147-50. PubMed ID: 26077493
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors.
Randolph JT; Li T; Chris Krueger A; Heyman HR; Chen HJ; Bow DAJ; Van Handel C; Peterkin V; Carr RA; Stolarik D; Dekhtyar T; Irvin M; Krishnan P; Wagner R; DeGoey DA
Bioorg Med Chem Lett; 2020 Apr; 30(7):126986. PubMed ID: 32046903
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of
Wang G; Dyatkina N; Prhavc M; Williams C; Serebryany V; Hu Y; Huang Y; Wu X; Chen T; Huang W; Rajwanshi VK; Deval J; Fung A; Jin Z; Stoycheva A; Shaw K; Gupta K; Tam Y; Jekle A; Smith DB; Beigelman L
J Med Chem; 2020 Sep; 63(18):10380-10395. PubMed ID: 32816483
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.
Tomassini JE; Getty K; Stahlhut MW; Shim S; Bhat B; Eldrup AB; Prakash TP; Carroll SS; Flores O; MacCoss M; McMasters DR; Migliaccio G; Olsen DB
Antimicrob Agents Chemother; 2005 May; 49(5):2050-8. PubMed ID: 15855531
[TBL] [Abstract][Full Text] [Related]
33. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Antiviral Activity of a Series of 2'-
Dentmon ZW; Kaiser TM; Liotta DC
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171951
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of a novel β-D-2'-deoxy-2'-α-fluoro-2'-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection.
Li E; Wang Y; Yu W; Lv Z; Peng Y; Liu B; Li S; Ho W; Wang Q; Li H; Chang J
Eur J Med Chem; 2018 Jan; 143():107-113. PubMed ID: 29172078
[TBL] [Abstract][Full Text] [Related]
36. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.
Bourdin C; McGuigan C; Brancale A; Chamberlain S; Vernachio J; Hutchins J; Gorovits E; Kolykhalov A; Muhammad J; Patti J; Henson G; Bleiman B; Bryant KD; Ganguly B; Hunley D; Obikhod A; Walters CR; Wang J; Ramamurty CV; Battina SK; Srivinas Rao C
Bioorg Med Chem Lett; 2013 Apr; 23(7):2260-4. PubMed ID: 23453067
[TBL] [Abstract][Full Text] [Related]
38. Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.
Tyndall EM; Draffan AG; Frey B; Pool B; Halim R; Jahangiri S; Bond S; Wirth V; Luttick A; Tilmanis D; Thomas J; Porter K; Tucker SP
Bioorg Med Chem Lett; 2015 Feb; 25(4):869-73. PubMed ID: 25592710
[TBL] [Abstract][Full Text] [Related]
39. Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
Shi ST; Herlihy KJ; Graham JP; Nonomiya J; Rahavendran SV; Skor H; Irvine R; Binford S; Tatlock J; Li H; Gonzalez J; Linton A; Patick AK; Lewis C
Antimicrob Agents Chemother; 2009 Jun; 53(6):2544-52. PubMed ID: 19307358
[TBL] [Abstract][Full Text] [Related]
40. 2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.
Zhou S; Mahmoud S; Liu P; Zhou L; Ehteshami M; Bassit L; Tao S; Domaoal RA; Sari O; Schutter C; Amiralaei S; Khalil A; Ollinger Russell O; McBrayer T; Whitaker T; Abou-Taleb N; Amblard F; Coats SJ; Schinazi RF
J Med Chem; 2017 Jul; 60(13):5424-5437. PubMed ID: 28595015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
